GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Shimadzu 7701.T · JPY

Information Technology · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

4,506

+8.06%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Shimadzu

Its shares trade on Tokyo Stock Exchange under the ticker 7701.T. It has been listed since 16 May 1949. In the fiscal year to 31 March 2026, it reported revenue of ¥560.73bn and net income of ¥60.50bn. At that date it held total assets of ¥737.98bn and shareholders' equity of ¥565.16bn.

Shimadzu Corp. engages in the manufacture and sale of testing, measuring, medical, aircraft and analytical instruments. The company is headquartered in Kyoto, Kyoto-Fu. The firm has four segments. The Testing and Measuring Instruments segment is engaged in the provision of chromatographic analysis systems, mass spectrometry systems, light analysis systems, thermal analysis systems, bio-related analysis systems, water quality measurement systems and others. The Medical Equipment segment is engaged in the provision of X-ray television (TV) systems, angiography systems, X-ray imaging systems and others. The Aircraft Equipment segment is engaged in the provision of flight control systems, air management systems, cockpit display systems and others. The Industrial Equipment segment is engaged in the provision of turbomolecular pumps and others. The firm also engaged in the real estate leasing business and other businesses.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Information Technology
Industry
Electronic Equipment, Instruments & Components
Listed since
16 May 1949
Employees
13,182

Leadership

Pay as last reported

  • Mr. Teruhisa UedaChairman of the Board, Chairman of the Board of Directors, Executive Officer, Representative Director, since 2007¥125.0m
  • Mr. Yasunori YamamotoPresident, Chief Executive Officer, Executive Officer, Representative Director, since 2015¥130.0m
  • Mr. Akira WatanabeSenior Managing Executive Officer, Chief Financial Officer, Director, since 2016
  • Mr. Hiroto ItoiManaging Executive Officer, Chief Technology Officer
  • Mr. Shuzo MaruyamaSenior Managing Executive Officer, Director, since 2013
  • Mr. Fuminori InagakiSenior Managing Executive Officer, Chief Strategy Officer
  • Mr. Katsuaki KaitoSenior Managing Executive Officer
  • Mr. Shunei MatobaManaging Executive Officer, Chief Director of Sales, President of Tokyo Office
  • Mr. Koki AoyamaManaging Executive Officer, President of Subsidiary
  • Mr. Shigenori AoyamaManaging Executive Officer
  • Mr. Yoshino KajitaniManaging Executive Officer
  • Mr. Kiyohito SonokiManaging Executive Officer, Director of Medical Equipment Business

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
90
Environment
99
Social
98
Governance
73
Direct emissions (scope 1)
2,748 t
Energy emissions (scope 2)
8,029 t
Value chain emissions (scope 3)
2,140,000 t
Women in the workforce
21.4%
Carbon reduction policy
No
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Strong brand reputation in the scientific instrumentation industry.
  • Diverse product portfolio, offering a wide range of high-quality analytical instruments.
  • Robust research and development capabilities, enabling continuous innovation.
  • Extensive global presence with a well-established distribution network.
  • Strong customer relationships and loyalty due to exceptional customer service.

Weaknesses

  • Relatively high pricing compared to some competitors, limiting market penetration.
  • Heavy dependence on the scientific research sector, making the company vulnerable to fluctuations in funding.
  • Limited presence in emerging markets, reducing growth opportunities.
  • Mergers and acquisitions strategy may create integration challenges and cultural differences.

Opportunities

  • Increasing demand for advanced analytical instruments in various industries.
  • Growing focus on healthcare and diagnostics, providing opportunities for expansion.
  • Technological advancements and automation trends driving demand for innovative solutions.
  • Expansion into emerging markets with untapped potential for scientific instrumentation.

Threats

  • Intense competition from major players and smaller niche competitors.
  • Economic downturns and funding cuts impacting research and development budgets.
  • Rapidly evolving technology requiring continuous investment to stay competitive.
  • Risk of intellectual property theft and infringement affecting market share.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.